Acadia Pharmaceuticals develops and commercializes innovative therapies for neurological and rare diseases, including the first FDA-approved treatments for Parkinson’s disease psychosis and Rett syndrome. Our focus is on harnessing scientific advancements to address critical needs in underserved ...
